Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-18

Clinical Trial Update: Cetuximab Plus Combination Chemotherapy in Treating Patients With Stage IV Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating cetuximab in combination with chemotherapy for stage IV colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetuximab (cetuximab)
  • Chemotherapy (unspecified regimen)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED